Cullinan Therapeutics CGEM
NASDAQ CGEM
$14.37 -0.55 (-3.69%)
At close: Oct 23, 2026 · 4:00 PM EDT

Cullinan Therapeutics (CGEM) Non-Current Debt (2022)

Updated

Analysis

Cullinan Therapeutics (CGEM) Non-Current Debt (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 35.80 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 62.48 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 23.68 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 23.83 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 60.50 Bn
10 Cullinan Therapeutics 894.26 Mn 559.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 1.40 Mn
Mar 31, 2022 800,000.00
API Access

Cullinan Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=CGEM&period=max&api_key=YOUR_API_KEY